IQVIA HOLDINGS INC. (IQV) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
61/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseIQV / S&P 13.30% / 15.20% |
LoseIQV / S&P IQV unavailable / 15.00% |
LoseIQV / S&P IQV unavailable / 50.40% |
| 2026-Q10/3 |
LoseIQV / S&P -24.34% / -4.33% |
LoseIQV / S&P 7.32% / 11.30% |
LoseIQV / S&P 9.96% / 27.70% |
| 2025-Q41/3 |
WinIQV / S&P 18.67% / 2.65% |
LoseIQV / S&P 5.87% / 9.00% |
LoseIQV / S&P 4.81% / 13.40% |
| 2025-Q31/3 |
WinIQV / S&P 20.53% / 8.12% |
LoseIQV / S&P 3.85% / 4.61% |
LoseIQV / S&P -4.34% / 13.45% |
| 2025-Q20/3 |
LoseIQV / S&P -10.61% / 10.94% |
LoseIQV / S&P 3.60% / 4.83% |
LoseIQV / S&P -10.27% / 10.63% |
| 2025-Q10/3 |
LoseIQV / S&P -10.28% / -4.27% |
LoseIQV / S&P 2.84% / 4.98% |
LoseIQV / S&P 0.27% / 10.57% |
| 2024-Q40/3 |
LoseIQV / S&P -17.07% / 2.41% |
LoseIQV / S&P 2.81% / 5.25% |
LoseIQV / S&P 2.88% / 6.15% |
| 2024-Q32/3 |
WinIQV / S&P 12.07% / 5.89% |
LoseIQV / S&P 3.10% / 5.89% |
WinIQV / S&P 27.90% / 6.11% |
| 2024-Q21/3 |
LoseIQV / S&P -16.39% / 4.28% |
LoseIQV / S&P 3.23% / 5.38% |
WinIQV / S&P 32.36% / 5.12% |
| 2024-Q11/3 |
LoseIQV / S&P 9.30% / 10.56% |
LoseIQV / S&P 3.97% / 5.71% |
WinIQV / S&P 31.47% / 5.59% |
| 2023-Q42/3 |
WinIQV / S&P 17.60% / 11.69% |
LoseIQV / S&P 3.98% / 6.81% |
WinIQV / S&P 27.50% / 7.78% |
| 2023-Q31/3 |
LoseIQV / S&P -12.47% / -3.27% |
LoseIQV / S&P 3.83% / 7.52% |
WinIQV / S&P -3.09% / -5.03% |
| 2023-Q22/3 |
WinIQV / S&P 13.01% / 8.74% |
LoseIQV / S&P 3.86% / 9.50% |
WinIQV / S&P -3.01% / -8.57% |
| 2023-Q11/3 |
LoseIQV / S&P -2.93% / 7.50% |
LoseIQV / S&P 3.29% / 10.77% |
WinIQV / S&P 0.18% / -15.69% |
| 2022-Q42/3 |
WinIQV / S&P 13.11% / 7.56% |
LoseIQV / S&P 3.86% / 11.88% |
WinIQV / S&P 15.12% / -17.99% |
| 2022-Q31/3 |
LoseIQV / S&P -16.52% / -4.88% |
LoseIQV / S&P 5.70% / 13.47% |
WinIQV / S&P 55.84% / -1.41% |
| 2022-Q22/3 |
WinIQV / S&P -6.15% / -16.10% |
LoseIQV / S&P 9.32% / 13.71% |
WinIQV / S&P 91.99% / 11.04% |
| 2022-Q12/3 |
LoseIQV / S&P -18.05% / -4.60% |
WinIQV / S&P 16.81% / 15.97% |
WinIQV / S&P 164.29% / 42.23% |
| 2021-Q43/3 |
WinIQV / S&P 17.78% / 11.03% |
WinIQV / S&P 22.14% / 15.00% |
WinIQV / S&P 246.85% / 96.40% |
| 2021-Q32/3 |
LoseIQV / S&P -1.15% / 0.58% |
WinIQV / S&P 23.55% / 10.77% |
WinIQV / S&P 332.97% / 69.42% |
| 2021-Q23/3 |
WinIQV / S&P 25.46% / 8.55% |
WinIQV / S&P 18.21% / 6.58% |
WinIQV / S&P 358.82% / 51.81% |
| 2021-Q13/3 |
WinIQV / S&P 7.80% / 6.17% |
WinIQV / S&P 7.67% / -1.06% |
WinIQV / S&P 90.91% / 7.39% |
| 2020-Q43/3 |
WinIQV / S&P 13.66% / 12.15% |
WinIQV / S&P 2.44% / -3.72% |
WinIQV / S&P 47.42% / -33.42% |
| 2020-Q33/3 |
WinIQV / S&P 11.10% / 8.93% |
WinIQV / S&P 0.69% / -2.04% |
WinIQV / S&P -24.79% / -27.10% |
| 2020-Q22/3 |
WinIQV / S&P 31.54% / 20.54% |
WinIQV / S&P 2.18% / -0.46% |
LoseIQV / S&P -43.80% / -27.11% |
| 2020-Q12/3 |
LoseIQV / S&P -30.19% / -19.60% |
WinIQV / S&P 5.93% / 3.47% |
WinIQV / S&P -8.33% / -14.75% |
| 2019-Q41/3 |
LoseIQV / S&P 3.43% / 9.07% |
WinIQV / S&P 6.49% / 5.36% |
LoseIQV / S&P -21.14% / 2.99% |
| 2019-Q31/3 |
LoseIQV / S&P -7.16% / 1.70% |
WinIQV / S&P 6.21% / 5.02% |
LoseIQV / S&P -78.12% / 0.21% |
| 2019-Q21/3 |
WinIQV / S&P 11.85% / 4.30% |
LoseIQV / S&P 5.82% / 6.64% |
LoseIQV / S&P -78.55% / 8.65% |
| 2019-Q11/3 |
WinIQV / S&P 23.83% / 13.65% |
LoseIQV / S&P 6.34% / 8.12% |
LoseIQV / S&P -78.69% / 14.29% |
| 2018-Q41/3 |
WinIQV / S&P -10.46% / -13.52% |
LoseIQV / S&P 7.32% / 9.05% |
LoseIQV / S&P -78.57% / 18.23% |
| 2018-Q31/3 |
WinIQV / S&P 29.97% / 7.71% |
LoseIQV / S&P 8.34% / 10.21% |
LoseIQV / S&P -766.27% / 19.06% |
| 2018-Q21/3 |
LoseIQV / S&P 1.74% / 3.43% |
WinIQV / S&P 19.21% / 9.03% |
LoseIQV / S&P -1475.61% / 14.46% |
| 2018-Q13/3 |
WinIQV / S&P 0.21% / -0.76% |
WinIQV / S&P 28.89% / 7.68% |
WinIQV / S&P 28050.00% / 12.46% |
| 2017-Q42/3 |
LoseIQV / S&P 2.98% / 6.64% |
WinIQV / S&P 42.36% / 7.03% |
WinIQV / S&P 1121.28% / 13.82% |
| 2017-Q32/3 |
WinIQV / S&P 6.22% / 4.48% |
WinIQV / S&P 56.01% / 5.68% |
LoseIQV / S&P -125.54% / 17.57% |
| 2017-Q22/3 |
WinIQV / S&P 11.14% / 3.09% |
WinIQV / S&P 41.71% / 4.83% |
LoseIQV / S&P -112.35% / 17.74% |
| 2017-Q11/3 |
LoseIQV / S&P 5.89% / 6.07% |
WinIQV / S&P 30.71% / 3.67% |
LoseIQV / S&P -99.39% / 13.32% |
| 2016-Q41/3 |
LoseIQV / S&P -6.18% / 3.82% |
WinIQV / S&P 18.79% / 2.09% |
LoseIQV / S&P -84.74% / 7.05% |
| 2016-Q33/3 |
WinIQV / S&P 24.10% / 3.85% |
WinIQV / S&P 7.72% / 0.20% |
WinIQV / S&P 10.92% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | IQV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 37.51% | 20.78% |
| Annualized return | 37.51% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | IQV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 0.06% | 83.14% |
| Annualized return | 0.01% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | IQV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 238.90% | 319.30% |
| Annualized return | 12.98% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |